GlassScriptPhysician profile
Anthony J Damore
NPI 1932131307
$1,643.87
in general payments reported to CMS, 2019-2025
13 companies · $130 in 2025
The $130 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2020: $69.70 · 2021: $244 · 2022: $234 · 2023: $335 · 2024: $378 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $843.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $843.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $510.48 | 2023-2025 | |
| Therapeuticsmd, INC. | $404.10 | 2019-2022 | |
| Pfizer INC. | $210.55 | 2019-2023 | |
| Ascend Therapeutics US, LLC | $164.33 | 2020-2024 | |
| Astellas Pharma US INC | $112.86 | 2023-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $57.07 | 2023-2025 | Myfembree, Gemtesa |
| Myovant Sciences INC. | $39.42 | 2021 | |
| Exact Sciences Corporation | $37.01 | 2024-2025 | Cologuard Collection Kit |
| Abbvie INC. | $32.12 | 2022 | |
| Becton, Dickinson and Company | $23.86 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.41 | 2019 | |
| Avion Pharmaceuticals | $15.32 | 2022 | |
| Amag Pharmaceuticals, INC. | $14.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Damore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.